(Q34636404)

3 August 2017

1 reference

title

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Lorna Watson

1

1 reference

3 August 2017

Brenda J Wilson

series ordinal

2

1 reference

3 August 2017

Norman Waugh

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

20

1 reference

3 August 2017

17-18

1 reference

3 August 2017

2166-2173

1 reference

Continuing challenge of pneumococcal disease.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

The pneumococcal problem

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Immunization of elderly people with polyvalent pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Pneumococcal vaccine campaign based in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Invasive pneumococcal disease in central Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Effect of underlying disease and age on pneumococcal serotype distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Meta-analysis and the meta-epidemiology of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Pneumococcal Vaccine in the Institutionalized Elderly: Design of a Nonrandomized Trial and Preliminary Results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Cholesterol lowering and mortality: the importance of considering initial level of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

Are randomized controlled trials sufficient evidence to guide clinical practice in type II (non-insulin-dependent) diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900112-3

7 January 2021

10.1016/S0264-410X(02)00112-3

Identifiers

DOI

1 reference

3 August 2017

1 reference